Pharmafile Logo

B2B sales

- PMLiVE

Retaining reader value in plain language summaries of clinical studies

Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries

- PMLiVE

Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?

Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...

Page & Page Health

- PMLiVE

Ocrevus surge keeps Roche smiling in Q3

MS drug is performing well, but immuno-oncology contender is in the doldrums

- PMLiVE

Genomics England chooses Congenica for diagnostic decision support

The company will provide diagnostic decision support services

- PMLiVE

First Humira biosimilars reach EU market

World's biggest selling medicine to lose billions in sales

- PMLiVE

Making Europe a leader in bioscience: boosting trust and opening minds

A vision of Paris as Europe's leading hub for life sciences innovation

- PMLiVE

Joint working that works

How can healthcare adapt?

- PMLiVE

AZ says UK investments on hold until there is Brexit ‘clarity’

Tomorrow's EU summit could be make-or-break for Brexit deal

- PMLiVE

Q&A: Kate Pain

Gemma Jones interviews Pfizer's digital marketing lead

- PMLiVE

Cancer disruptor F Star names next CEO

Dr Eliot Forster takes reins from Dr John Haurum

- PMLiVE

US says medicine ads should include list prices

Hopes the proposal will encourage lower prescription drug prices

- PMLiVE

UK pharma leader warns on ‘untenable’ Brexit deal

Draft agreement is a major step back for UK

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links